be_ixf;ym_202605 d_03; ct_100

Latest Insights on HUMA

Intel Says You Should Buy Mobileye Meme Intel Mobilizes Mobileye; AutoZoning Out; Hydrogen’s Battery Assault December 7, 2021 by Joseph Hargett Great Stuff What Do You Do With A Drunken Intel? Great Ones, Intel (Nasdaq: ) was back in the headlines today, but not because it finally solved its productions problems. No, Intel is back in the headlines because it officially announced that it’s spinning off Mobileye — the AI self-driving vehicle unit it picked up back in […]
Wake Up Great Stuff Metaverse Matrix has you meme 5 Stocks To Rule The Metaverse December 4, 2021 by Joseph Hargett Great Stuff What’s The Deal With The Metaverse? Great Ones, I’ve been reluctant to talk about the so-called “metaverse” for a multitude of reasons. The first of which is that the metaverse is all but sure to fall short of my childhood dreams. I mean, I grew up on fantasy and sci-fi flicks and Saturday morning cartoons. […]
Boeing 737 Max cleared in China for takeoff dog meme Boeing Bites Back; Whistling Tesla; Dolla Dolla General December 2, 2021 by Joseph Hargett Great Stuff A Flight Of Fancy On A Windswept Field Into the distance, a ribbon of sell-offs … stretched to the point of no turning back. Great Ones, I can’t keep my eyes from the circling sky today. Tongue-tied and twisted. Just an earthbound misfit, I … by golly, by gosh, I think Boeing’s (NYSE: ) learning […]
Hold on, roller coaster omicron market correction main image Omicron’s Market Madness, Meta’s Gif Horse & Raptor’s Wreckage November 30, 2021 by Joseph Hargett Great Stuff Don’t Panic & Carry A Towel The market gets to the bottom then goes back to the top of the slide, where it stops and it turns and it goes for a ride … ‘till it gets to the bottom and it does it again! Yeah, yeah, yeah! Do you, don’t you want me to […]
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 by Ted Bauman Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

“Looks like I have finally found the right person to learn and grow from.”

- James

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

Share This